Management Participants
The call was moderated by Ms. Hanishi Shah from Adfactors PR. Management participants included:
- Mr. Arjun Lamba – Managing Director, Religare Enterprises Limited
- Mr. Pratul Gupta – Chief Financial Officer, Religare Enterprises Limited
- Management team of Religare Enterprises Limited and its subsidiaries
- Mr. Ambrish Jindal – CFO, Care Health Insurance
- Mr. Ajay Shah – Management, Care Health Insurance
- Mr. Karthik Srinivasan – Management, Religare Finvest Limited
- Mr. Prakash Jejani – Management (presumed for RFL)
Key Financial Figures - Consolidated (H1 FY27)
- Total Income: ₹4,717 crores (19% YoY growth)
- Loss After Tax: ₹145 crores
- Net Worth: Approximately ₹3,000 crores as of September 30, 2026
Key Financial Figures - Consolidated (Q2 FY27)
- Total Income: ₹2,390 crores
- Total Expenses: ₹2,518 crores
- Loss Before Tax: ₹128 crores
Key Financial Figures - Standalone REL (Q2 FY27)
- Income: ₹3+ crores
- Expenses: ₹16 crores
- Loss: ₹13 crores
Key Financial Figures - Standalone REL (H1 FY27)
- Income: ₹8 crores
- Expenses: ₹31 crores
- Loss: ₹23 crores
Business Segment Updates
Religare Broking Limited (RBL)
- Market activity was subdued during the quarter with regulatory changes weighing on trading volumes
- H1 FY27 Performance:
- Total Income: ₹197 crores (7% growth)
- Profit Before Tax: ₹13 crores (29% growth)
- Assets Under Custody: ₹56,000+ crores
- Revenue Mix: Brokerage (46%), Interest Income (32%), E-governance (10%), Depository Services & Third-party products (balance)
- Q2 FY27 Performance:
- Total Income: ₹97.4 crores (9% YoY growth)
- PAT: ₹2.5 crores (broadly flat vs. ₹2.6 crores last year)
- Consolidated Net Worth: ₹488 crores (mainly due to capital infusion)
- Key Metrics:
- Cash Segment Average Daily Turnover: grew from ₹274 crores to ₹320 crores YoY
- Derivatives ADTO: rose 12%
- Unique Traded Clients: increased marginally QoQ
- Capital Infusion: REL infused ₹100 crores into RBL through rights issue in August 2026
- Rating Updates:
- CRISIL upgraded long-term rating to CRISIL BBB+ Stable from CRISIL BBB Stable
- CRISIL upgraded short-term rating
- CARE Ratings reaffirmed at CARE BBB+ and CARE A2
Religare Finvest Limited (RFL)
- Resumed lending after 10 years, disbursed first loan just before Diwali
- Product Offerings: Loans against property, business loans, and used car loans to salaried and self-employed borrowers, small business owners, and traders
- Branch Openings (November 2026): Lucknow, Kanpur, and Noida (Uttar Pradesh)
- Future Expansion: Tamil Nadu, Rajasthan, and Maharashtra
- Business Approach: Secured-first retail lending, tech-led underwriting with branch-led relationships
- Financial Position:
- Legacy SME Book: ₹43 crores
- H1 FY27 PAT: ₹64.5 crores
- Net Owned Funds: ₹891 crores
- Tangible Net Worth: ₹963 crores
- Cash & Liquid Investments: ₹660 crores
- Net NPA: Nil
- CRAR: 230%+ (well above regulatory requirements)
- Q2 FY27 Performance:
- Total Income: ₹44.8 crores (vs. ₹20 crores in Q2 FY26)
- PAT: ₹49 crores (vs. ₹30.8 crores in Q2 FY26)
- Net Interest Income: ₹39.3 crores (vs. ₹18.5 crores previous year)
- Collection Efficiency: ~100%
- Performance driven by healthy recoveries from GNPA book
Religare Housing Development Finance Corporation Limited (RHDFCL)
- Focus: Self-employed and informal segment customers in semi-urban markets
- Current Operations:
- 2,700 customers through 15 branches in 8 states
- 57% customers self-employed
- Over 50% have bureau scores above 700
- Average Ticket Size: ₹11 lakhs
- Portfolio LTV: ~46%
- AUM: Above ₹240 crores (67% home loans, 33% loans against property)
- Capital Position:
- Net Worth: ₹170+ crores
- Capital Adequacy: 117%
- No external borrowings
- Capital Commitment: REL committed ₹250 crores of capital to strengthen balance sheet
- Q2 FY27 Performance:
- Net Interest Income: ₹6.6 crores (H1)
- Operating Expenses: ₹17 crores (H1, due to higher depreciation and technology costs)
- Loss: ₹8 crores (Q2) vs. ₹5 crores (Q1)
- Collection Efforts: Reduced delinquencies, brought 1+ pool down to 19%
- Focus: Home loans for self-construction, identifying high-potential DSAs and connector partners
- Maintains investment-grade ratings
Care Health Insurance Limited
- Position: Second-largest standalone health insurer in India
- H1 FY27 Performance (Ind AS basis):
- Gross Written Premium (GWP): ₹6,897 crores (35% growth, full premium basis)
- Retail Business Growth: 44% YoY (full premium basis)
- Profit Before Tax: ₹392 crores (vs. ₹276 crores in H1 FY26, 42% growth)
- Claim Ratio: 66.1% (improved by 90 bps)
- Combined Operating Ratio: 100.5% (improved by 70 bps)
- Return on Equity (PBT basis): 12.1% (from 10.2%)
- Market Share: 7.3% overall, 24% within SAHI segment
- Investment AUM: ₹12,900 crores
- Claim Settlement Ratio: 97%
- Capital Raising:
- Raised ₹300 crores in Tier 2 capital during quarter
- Raised another ₹150 crores in Tier 2 capital in October 2026
- Business Metrics:
- Retail Health Market Share: 12.8% (industry), 21.3% (SAHIs)
- Multi-year Business: 18-20% of retail overall
- Distribution Mix: Proprietary channel (47%), D2C growth (60%+)
- Retail Persistency Rate: improved to 97% from 91%
- Digital Transformation:
- 99.5% policies issued digitally
- 80% cashless claims processed within 30 minutes
- Cashless Claim NPS: 74
- App Installations: 13.8 million
- Active Users: 1.2 million
- 67% active retail customers on mobile app
- Financial Performance (1/n basis - transition years, not comparable):
- Showing loss due to accounting transition from October 2024 regulation change
- Expected to normalize from October 2027 onwards
- Solvency Position:
- Current solvency ratio: 1.55x (calculated on I-GAAP basis)
- Difference in net worth between I-GAAP and Ind AS: ~₹1,000+ crores
- Planning ₹300 crores rights issue in November 2026
Corporate Governance Updates
- RBI approved appointment of new directors: Dr. Anand Burman, Mr. Aditya Burman, Mr. Mohit Burman, and Jimeet Modi
- These are promoter and shareholder directors
- Corporate offices moved to Mumbai
Strategic Priorities and Guidance
- Demerger/Restructuring: High priority item, in touch with regulators and advisors
- Business Build-out Timeline: 24 months for full potential realization
- RFL Growth Targets:
- Current Year Disbursement: <₹100 crores
- FY28 Disbursement Target: ₹1,500-1,700 crores
- Long-term AUM Target: ₹10,000-15,000 crores over 4-5 years
- Target ROA: 2.5-2.8%
- Target Yield: 15.5%
- Care Health Insurance Guidance:
- Expect to maintain growth better than industry rates
- Combined ratio expected to improve further
- Awaiting IRDAI draft regulations on distribution and solvency calculation
Warrant Conversion Update
- Total Warrants: ₹1,500 crores
- Funds Received: ₹619 crores (25% - ₹375 crores at subscription, ₹243 crores incremental conversions over last year)
- Remaining: ₹880 crores, maturity in March 2027
- Funds used for infusion into Care Health Insurance (rights issue) and broking business